Termination of trial of streptokinase in severe acute ischaemic stroke

The Lancet

Volumn 345, Issue 8941, 1995, Pages 57-

  Hommel, M ^a   Boissel, J P ^a   Cornu, C ^a   Boutitie, F ^a   Lees, K R ^a   Besson, G ^a   Leys, D ^a   Amarenco, P ^a   Bogaert, M ^a   MAST Study Group, ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028836677     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91179-0     Document Type: Letter

References (3)

1. Thrombolysis in acute stroke: does it work?
2. Protocol for the Multicentre Acute Stroke Trial— Thrombolysis study